Nascent Biotech Inc. (NBIO)
Market Open
8 Dec, 14:31
OTCQB OTCQB Primary $
0. 00
-0
-76.74%
$
15.67M Market Cap
- P/E Ratio
0% Div Yield
208,264 Volume
0 Eps
$ 0
Previous Close Day Range
0 0
Year Range
0 0.13
Want to track NBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nascent Biotech Presents at the July Emerging Growth Conference
Nascent CEO-Sean Carrick-Discusses Phase I Results and Forward Clinical Strategy while laying out Investment Opportunity of the Company NORTH PALM BEACH, FL / ACCESSWIRE / July 30, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, is pleased to provide an overview of the Company's presentation at The Emerging Growth Conference on July 18, 2024. Click here to view the Company's entire presentation.
Accesswire | 1 year ago
2025 © Marketlog. All Rights Reserved.
